Caption Management, LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $739,100 - $1.35 Million	-95,000 Reduced 73.08%	35,000 $280,000
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $1.1 Million - $2.53 Million	-145,000 Reduced 52.73%	130,000 $1.93 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $585,750 - $1.58 Million	177,500 Added 182.05%	275,000 $2.24 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $299,700 - $593,325	67,500 Added 225.0%	97,500 $443,000
Q1 2023 May 15, 2023	BUY	$5.53 - $8.22 $165,900 - $246,600	30,000 New	30,000 $183,000
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $1.83 Million - $2.4 Million	90,000 Added 300.0%	120,000 $2.96 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $539,700 - $780,000	30,000 New	30,000 $546,000

312

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.